Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Type A trichothecene mycotoxin produced by Fusa...
Multikinase inhibitor.
Modifies microvascular function
Found in propolis; 5-lipoxygenase inhibitor.
Docetaxel impurity
Abl, c-Kit, PDGFR inhibitor.
Lignin found in Sesamin indicum;
Nucleoside (deoxyadenosine) analog found in Co...
p110α PI3K inhibitor.
c-MET inhibitor.
Peptide found in insects.
Thiopurine antimetabolite; PRPP amidotransferas...
Synthetic steroid; glucocorticoid agonist.
Collagen synthesis inhibitor.
Endogenous NMDA receptor antagonist.
TGF-β1 inhibitor.
NSAID; CB1 agonist, COX-2 inhibitor.
Degrades of BET proteins.
Fumaric acid methyl ester; nAChR agonist, indir...
Sesquiterpene lactone derived from Artemesia; m...